ISSUE: The FDA announced it is requesting manufacturers to withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
April 1, 2020
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
March 30, 2020
Distributed via the CDC Health Alert Network
Centers for Medicare & Medicaid Services (CMS) released two comprehensive toolkits on telehealth that are specific to general practitioners as well as providers treating patients with End-Stage Renal Disease (ESRD).
Today, the Centers for Disease Control and Prevention (CDC) released new information on two critical areas of care related to Coronavirus Disease-2019 (COVID-19).
CMS COVID-19 Resources
Revaclear Capillary Dialyzer 300, REF Revaclear 300 Product Code 114745L
Reason for Recall:
The U.S. Food and Drug Administration (FDA) is informing patients, health care providers and facility staff, and manufacturers about cybersecurity vulnerabilities that may introduce risks for certain medical devices and hospital networks.
September 23, 2019